Metabolic syndrome components and colorectal adenoma in the CLUE II cohort

Konstantinos K. Tsilidis, Frederick L. Brancati, Michael N. Pollak, Nader Rifai, Sandra L. Clipp, Judith Hoffman-Bolton, Kathy J. Helzlsouer, Elizabeth A. Platz

Research output: Contribution to journalArticle

Abstract

Background: Metabolic syndrome components have been associated with colorectal cancer in several studies; however, evidence for colorectal adenomas is limited. Thus, we evaluated the association between markers of the metabolic syndrome with colorectal adenoma development in a nested case-control study. Methods: Colorectal adenoma cases (n = 132) and matched controls, who had a negative sigmoidoscopy or a colonoscopy (n = 260), were identified between baseline in 1989 and 2000 among participants in the CLUE II cohort of Washington County, Maryland. Concentrations of C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, total cholesterol, high-density lipoprotein cholesterol, and triglycerides were measured in baseline blood specimens. Body mass index was calculated using baseline height and weight. Use of medications to treat diabetes mellitus was self-reported at baseline. Blood pressure was measured at baseline. Distributional cutpoints of the latter markers were used to define the metabolic syndrome components (hyperinsulinemia, hyperglycemia, obesity, dyslipidemia, and hypertension) present at baseline. Results: No statistically significant associations with adenomas were observed for the markers of the metabolic syndrome, with the exception of a strong positive association for use of diabetes medications (OR, 8.00; 95% CI, 1.70-37.67), albeit based on small numbers. Conclusion: Our findings do not support that components of the metabolic syndrome influence risk of colorectal adenomas, except possibly for severe diabetes mellitus warranting medical treatment.

Original languageEnglish (US)
Pages (from-to)1-10
Number of pages10
JournalCancer Causes and Control
Volume21
Issue number1
DOIs
StatePublished - Jan 1 2010

Keywords

  • Colorectal neoplasia
  • Insulin resistance
  • Prospective study

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Metabolic syndrome components and colorectal adenoma in the CLUE II cohort'. Together they form a unique fingerprint.

  • Cite this

    Tsilidis, K. K., Brancati, F. L., Pollak, M. N., Rifai, N., Clipp, S. L., Hoffman-Bolton, J., Helzlsouer, K. J., & Platz, E. A. (2010). Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes and Control, 21(1), 1-10. https://doi.org/10.1007/s10552-009-9428-6